Current neurologic treatment and emerging therapies in CDKL5 deficiency disorder

BACKGROUND: CDKL5 deficiency disorder (CDD) is associated with refractory infantile onset epilepsy, global developmental delay, and variable features that include sleep, behavioral disturbances, and movement disorders. Current treatment is primarily symptom-based and informed by experience in caring...

Descripción completa

Detalles Bibliográficos
Autores principales: Olson, Heather E., Daniels, Carolyn I., Haviland, Isabel, Swanson, Lindsay C., Greene, Caitlin A., Denny, Anne Marie M., Demarest, Scott T., Pestana-Knight, Elia, Zhang, Xiaoming, Moosa, Ahsan N., Fidell, Andrea, Weisenberg, Judith L., Suter, Bernhard, Fu, Cary, Neul, Jeffrey L., Percy, Alan K., Marsh, Eric D., Benke, Timothy A., Poduri, Annapurna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447578/
https://www.ncbi.nlm.nih.gov/pubmed/34530725
http://dx.doi.org/10.1186/s11689-021-09384-z

Ejemplares similares

Ejemplares similares